Is docetaxel-prednisone (DP) feasible in frail elderly (75+) patient with castration-resistant metastatic prostate cancer (CRMPC)? A prospective randomized study after geriatric assessment from gerico and getug unicancer groups
Title:
Is docetaxel-prednisone (DP) feasible in frail elderly (75+) patient with castration-resistant metastatic prostate cancer (CRMPC)? A prospective randomized study after geriatric assessment from gerico and getug unicancer groups
Author:
Mourey, L. Gravis-Mescam, G. Sevin, E. Priou, F. Bompas, E. Sarda, C. Houede, N. Carola, E. Abadie, S. Latorzeff, I. Orsini, C. Filleron, T.